Global Good, a collaboration between the invention company Intellectual Ventures and the billionaire philanthropist Bill Gates, today announced a new partnership around a bioelectronic treatment initiative to address the leading cause of maternal deaths worldwide.
The fund, which is focused on inventing, developing, and deploying technologies for the poorest parts of the world, will partner with a health care research group and a medical device company to carry out clinical trials for the neural tourniquet device. The partnership aims to make this therapy available in developing regions, to reduce life threatening bleeding for mothers suffering from postpartum hemorrhage.
The collaboration is the latest of a growing number of examples of this Seattle-based innovation and invention lab identifying partners to get their products to some of the hardest markets in the world to reach.
About the author
Catherine Cheneycatherinecheney
Catherine Cheney is the Senior Editor for Special Coverage at Devex. She leads the editorial vision of Devex’s news events and editorial coverage of key moments on the global development calendar. Catherine joined Devex as a reporter, focusing on technology and innovation in making progress on the Sustainable Development Goals. Prior to joining Devex, Catherine earned her bachelor’s and master’s degrees from Yale University, and worked as a web producer for POLITICO, a reporter for World Politics Review, and special projects editor at NationSwell. She has reported domestically and internationally for outlets including The Atlantic and the Washington Post. Catherine also works for the Solutions Journalism Network, a non profit organization that supports journalists and news organizations to report on responses to problems.
